|
ADK expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.56650000004976E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.003030E-04 |
| Normal-vs-Stage2 |
1.019950E-03 |
| Normal-vs-Stage3 |
3.210600E-04 |
| Normal-vs-Stage4 |
7.713200E-01 |
| Stage1-vs-Stage2 |
6.068600E-01 |
| Stage1-vs-Stage3 |
2.943000E-01 |
| Stage1-vs-Stage4 |
2.508600E-01 |
| Stage2-vs-Stage3 |
7.017400E-01 |
| Stage2-vs-Stage4 |
1.887150E-01 |
| Stage3-vs-Stage4 |
1.459430E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.84084000000029E-05 |
| Normal-vs-AfricanAmerican |
2.232100E-02 |
| Normal-vs-Asian |
5.930400E-01 |
| Caucasian-vs-AfricanAmerican |
1.189860E-02 |
| Caucasian-vs-Asian |
1.768560E-01 |
| AfricanAmerican-vs-Asian |
3.020600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.69354999999261E-05 |
| Normal-vs-Female |
5.557500E-02 |
| Male-vs-Female |
2.122600E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.391180E-04 |
| Normal-vs-Extreme_Weight |
2.07689999999205E-05 |
| Normal-vs-Obese |
1.434100E-04 |
| Normal-vs-Extreme_Obese |
1.811430E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.504200E-01 |
| Normal_Weight-vs-Obese |
7.081200E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.943600E-01 |
| Extreme_Weight-vs-Obese |
3.836800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.531800E-01 |
| Obese-vs-Extreme_Obese |
3.708000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.631200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.01580000000379E-06 |
| Normal-vs-Age(61-80Yrs) |
1.59745999999128E-05 |
| Normal-vs-Age(81-100Yrs) |
2.173399999994E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.744200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.684400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.055220E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.478400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.597800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.407230E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.86880000000644E-05 |
| Normal-VS-Type2 PRCC |
5.021400E-04 |
| Normal-VS-KIRP CIMP |
6.764400E-01 |
| Normal-VS-Unclassified PRCC |
3.85179999999874E-05 |
| Type1 PRCC-VS-Type2 PRCC |
4.388000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.768000E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
6.066400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.237900E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.915800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.915900E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.12640000000408E-05 |
| Normal-vs-N1 |
3.391800E-02 |
| Normal-vs-N2 |
3.986500E-02 |
| N0-vs-N1 |
4.339600E-01 |
| N0-vs-N2 |
5.462400E-01 |
| N1-vs-N2 |
4.687800E-01 |
|
|
